224 related articles for article (PubMed ID: 24862139)
1. Predicting recurrent venous thromboembolism in cancer: is it possible?
Kyrle PA
Thromb Res; 2014 May; 133 Suppl 2():S17-22. PubMed ID: 24862139
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
3. Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.
Louzada ML; Carrier M; Lazo-Langner A; Dao V; Kovacs MJ; Ramsay TO; Rodger MA; Zhang J; Lee AY; Meyer G; Wells PS
Circulation; 2012 Jul; 126(4):448-54. PubMed ID: 22679142
[TBL] [Abstract][Full Text] [Related]
4. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation after venous thromboembolism. Deciding on the optimal duration.
Eichinger S
Hamostaseologie; 2013 Aug; 33(3):211-7. PubMed ID: 23719863
[TBL] [Abstract][Full Text] [Related]
7. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
Menapace LA; McCrae KR; Khorana AA
Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
[TBL] [Abstract][Full Text] [Related]
8. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
9. [Optimal duration of anticoagulation of venous thromboembolism].
Savina EN; Couturaud F
J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
[TBL] [Abstract][Full Text] [Related]
10. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
11. Clinical scores to predict recurrence risk of venous thromboembolism.
Kyrle PA; Eichinger S
Thromb Haemost; 2012 Dec; 108(6):1061-4. PubMed ID: 22872143
[TBL] [Abstract][Full Text] [Related]
12. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
[TBL] [Abstract][Full Text] [Related]
13. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
15. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
Couturaud F; Kearon C
Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in cancer patients.
Lee AY
Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
[TBL] [Abstract][Full Text] [Related]
17. Extended therapy for primary and secondary prevention of venous thromboembolism.
Conway SE; Marcy TR
J Pharm Pract; 2010 Aug; 23(4):313-23. PubMed ID: 21507831
[TBL] [Abstract][Full Text] [Related]
18. Duration of anticoagulation after venous thromboembolism in real world clinical practice.
Ageno W; Samperiz A; Caballero R; Dentali F; Di Micco P; Prandoni P; Becattini C; Uresandi F; Verhamme P; Monreal M;
Thromb Res; 2015 Apr; 135(4):666-72. PubMed ID: 25708926
[TBL] [Abstract][Full Text] [Related]
19. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
Kyrle PA; Eischer L
Hamostaseologie; 2013 Aug; 33(3):201-9. PubMed ID: 23712242
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
Pangilinan JM
J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]